Next 10 |
home / stock / nrxpw / nrxpw news
2024-05-14 20:11:06 ET NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Results Conference Call May 14, 2024 04:30 PM ET Company Participants Matthew Duffy - Company's Chief Business Officer Stephen Willard - Chief Executive Officer Jonathan Javitt - Founder, Chairman an...
2024-04-01 15:08:10 ET NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Conference Call April 1, 2024 08:30 ET Company Participants Matthew Duffy - Chief Business Officer Jonathan Javitt - Founder & Chief Scientist Stephen Willard - Chief Executive Officer ...
2023-11-14 19:35:31 ET NRX Pharmaceuticals, Inc. (NRXP) Q3 2023 Earnings Conference Call November 14, 2023 04:30 PM ET Company Participants Matthew Duffy - Chief Business Officer Stephen Willard - Chief Executive Officer Jonathan Javitt - Founder & Chief Scie...
2023-08-14 21:58:04 ET NRX Pharmaceuticals, Inc. (NRXP) Q2 2023 Earnings Conference Call August 14, 2023, 16:30 ET Company Participants Matthew Duffy - Chief Business Officer Steve Willard - CEO & Director Jonathan Javitt - Chief Scientist & Director ...
2023-05-16 13:33:07 ET NRx Pharmaceuticals, Inc. (NRXP) Q1 2023 Earnings Call May 16, 2023 8:30 AM ET Company Participants Suzanne Messere - Investor Relations, Stern Stephen Willard - Chief Executive Officer and Director Seth Van Voorhees - Chief Financial Offic...
2023-03-30 22:10:12 ET NRx Pharmaceuticals, Inc. (NRXP) Q4 2022 Earnings Conference Call March 30, 2023 04:30 PM ET Company Participants Suzanne Messere - IR Stephen Willard - CEO Seth Van Voorhees - CFO Jonathan Javitt - Chief Scientist Conference Call...
NRx Pharmaceuticals, Inc. (NRXP) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Suzanne Messere - Investor Relations Stephen Willard - Chief Executive Officer Seth Van Voorhees - Chief Financial Officer and Treasurer Jonath...
NRx Pharmaceuticals, Inc. (NRXP) Q2 2022 Earnings Conference Call August 15, 2022 08:30 AM ET Company Participants Tom Johnson - Investor Relations Stephen Willard - Chief Executive Officer Seth Van Voorhees - Chief Financial Officer & Treasurer Robert Be...
NRx Pharmaceuticals, Inc. (NRXP) Q4 2021 Earnings Conference Call March 31 2022, 08:30 AM ET Company Participants Eric Goldstein - MD, LifeSci Advisors, IR Robert Besthof - Interim CEO, Head of Operations & Chief Commercial Officer Ira Strassberg - CFO and Treasurer Conference Call Partic...
Results from ACTIV-3b study using ZYESAMI for treatment of hospitalized patients with Covid-19 are expected in 1st half of 2022. NDA approval expected in 2nd half of 2022 with successful data. Initiation of phase 3 study using NRX-101 for treatment of hospitalized bipolar depression p...
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Warrant Company Name:
NRXPW Stock Symbol:
NASDAQ Market:
NRX Pharmaceuticals Inc. Warrant Website: